- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hitachi forms nuclear medicine division
Japanese vendor Hitachi Medical of Tokyo has formed a new nuclearmedicine division to handle direct sales in North America of itsgamma cameras. The move culminates Hitachi's comeback in the modality,which began when Summit Nuclear stopped marketing the
Japanese vendor Hitachi Medical of Tokyo has formed a new nuclearmedicine division to handle direct sales in North America of itsgamma cameras. The move culminates Hitachi's comeback in the modality,which began when Summit Nuclear stopped marketing the Hitachiproducts following the merger of Summit and Sopha Medical (SCAN10/11/95).
Hitachi's Nuclear Medicine Products Division will be based inTwinsburg, OH, and will be a subsidiary of Hitachi Medical Corporationof America, which is based in Tarrytown, NY. Former Summit executiveGary Enos is general manager of the division.
At last month's Radiological Society of North America meeting,Hitachi displayed SpectraDigital V250 DSP, the company's variable-angledual-head gamma camera. The company also had panels on 511-keVcollimation and a work-in-progress Coincidence Detection Reconstruction(CDR) technique.
Hitachi is also developing a new nuclear medicine workstation,SpectraDigital 300SS, which is based on a Hewlett-Packard platformwith applications software developed in cooperation with MedasysDigital Systems. The computer is expected to be available earlythis year.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
